Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Hertraz 440mg Injection, containing the active ingredient Trastuzumab, is a targeted biological therapy used to treat HER2-positive cancers.
| Strength | 440 mg/Vial (Multiple Use Vial) |
| Main Ingrdients | Trastuzumab |
| Shelf Life | 36 Months |
| Uses | Cancer Treatment |